{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T11:44:46Z","timestamp":1774525486295,"version":"3.50.1"},"reference-count":18,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Joint Bone Spine"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.jbspin.2015.04.022","type":"journal-article","created":{"date-parts":[[2015,12,12]],"date-time":"2015-12-12T17:07:43Z","timestamp":1449940063000},"page":"173-178","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["Paradoxical anti-TNF-associated TB worsening: Frequency and factors associated with IRIS"],"prefix":"10.1016","volume":"83","author":[{"given":"Claire","family":"Rivoisy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florence","family":"Tubach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carine","family":"Roy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathalie","family":"Nicolas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xavier","family":"Mariette","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominique","family":"Salmon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivier","family":"Lortholary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Bourgarit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbspin.2015.04.022_bib0095","doi-asserted-by":"crossref","first-page":"191","DOI":"10.2165\/00003495-200868020-00004","article-title":"Immune reconstitution inflammatory syndrome in HIV-infected patients receiving antiretroviral therapy: pathogenesis, clinical manifestations and management","volume":"68","author":"Dhasmana","year":"2008","journal-title":"Drugs"},{"key":"10.1016\/j.jbspin.2015.04.022_bib0100","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/QCO.0b013e32832d7aff","article-title":"Immune reconstitution inflammatory syndrome in non-HIV immunocompromised patients","volume":"22","author":"Sun","year":"2009","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.jbspin.2015.04.022_bib0105","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1093\/qjmed\/hcq152","article-title":"TNF-\u03b1 antagonists beyond approved indications: stories of success and prospects for the future","volume":"103","author":"Karampetsou","year":"2010","journal-title":"QJM"},{"key":"10.1016\/j.jbspin.2015.04.022_bib0110","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1056\/NEJMoa011110","article-title":"Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent","volume":"345","author":"Keane","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jbspin.2015.04.022_bib0115","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.jbspin.2011.01.003","article-title":"Paradoxical exacerbation of tuberculosis after TNF\u03b1 antagonist discontinuation: Beware of immune reconstitution inflammatory syndrome","volume":"78","author":"Rivoisy","year":"2011","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.jbspin.2015.04.022_bib0120","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.rce.2011.07.024","article-title":"[Immune reconstitution syndrome in a case of disseminated tuberculosis after withdrawal of treatment with adalimumab]","volume":"212","author":"Jorge-Ripper","year":"2012","journal-title":"Rev Clin Esp"},{"key":"10.1016\/j.jbspin.2015.04.022_bib0125","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1002\/art.24632","article-title":"Risk of tuberculosis is higher with anti-tumor necrosis factor monoclonal antibody therapy than with soluble tumor necrosis factor receptor therapy: the three-year prospective French Research Axed on Tolerance of Biotherapies registry","volume":"60","author":"Tubach","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2015.04.022_bib0130","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/S1473-3099(08)70184-1","article-title":"Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settings","volume":"8","author":"Meintjes","year":"2008","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jbspin.2015.04.022_bib0135","series-title":"WHO Global tuberculosis report 2014","year":"2014"},{"key":"10.1016\/j.jbspin.2015.04.022_bib0140","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s10096-003-0998-z","article-title":"Risk factors for development of paradoxical response during antituberculosis therapy in HIV-negative patients","volume":"22","author":"Cheng","year":"2003","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jbspin.2015.04.022_bib0145","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1016\/j.semarthrit.2005.01.004","article-title":"Clinical pharmacokinetics of TNF antagonists: how do they differ?","volume":"34","author":"Nestorov","year":"2005","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2015.04.022_bib0150","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1097\/QAD.0b013e32833dfc68","article-title":"Randomized placebo-controlled trial of prednisone for paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome","volume":"24","author":"Meintjes","year":"2010","journal-title":"AIDS"},{"key":"10.1016\/j.jbspin.2015.04.022_bib0155","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1086\/527390","article-title":"Adjuvant corticosteroid therapy for chronic disseminated candidiasis","volume":"46","author":"Legrand","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jbspin.2015.04.022_bib0160","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jbspin.2014.09.002","article-title":"Immune reconstitution inflammatory syndrome during treatment of Whipple's disease","volume":"82","author":"Vayssade","year":"2015","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.jbspin.2015.04.022_bib0165","doi-asserted-by":"crossref","first-page":"e83","DOI":"10.1086\/592695","article-title":"Therapeutic use of infliximab in tuberculosis to control severe paradoxical reaction of the brain and lymph nodes","volume":"47","author":"Blackmore","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jbspin.2015.04.022_bib0170","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1086\/598504","article-title":"Adalimumab treatment of life-threatening tuberculosis","volume":"48","author":"Wallis","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jbspin.2015.04.022_bib0175","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1097\/QAD.0b013e328358daea","article-title":"Thalidomide for steroid-dependent immune reconstitution inflammatory syndromes during AIDS","volume":"23","author":"Brunel","year":"2012","journal-title":"AIDS"},{"key":"10.1016\/j.jbspin.2015.04.022_bib0180","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.jbspin.2013.10.007","article-title":"A severe Whipple disease with an immune reconstitution inflammatory syndrome: an additionnal case of thalidomide efficiency","volume":"81","author":"Le Blay","year":"2014","journal-title":"Joint Bone Spine"}],"container-title":["Joint Bone Spine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X15002559?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X15002559?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,11,18]],"date-time":"2022-11-18T09:47:35Z","timestamp":1668764855000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1297319X15002559"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":18,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["S1297319X15002559"],"URL":"https:\/\/doi.org\/10.1016\/j.jbspin.2015.04.022","relation":{},"ISSN":["1297-319X"],"issn-type":[{"value":"1297-319X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Paradoxical anti-TNF-associated TB worsening: Frequency and factors associated with IRIS","name":"articletitle","label":"Article Title"},{"value":"Joint Bone Spine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbspin.2015.04.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Soci\u00e9t\u00e9 fran\u00e7aise de rhumatologie. Published by Elsevier Masson SAS All rights reserved.","name":"copyright","label":"Copyright"}]}}